We are live on ! Find out more
OMIC

Singular Genomics Systems, Inc. Common Stock
OMIC

Delisted

OMIC was delisted on the 20th of February, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Singular Genomics Systems, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 20 → 0 (-20)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $21.5M → $0 (-$21.5M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 20

Holders
–
Holders Change
-20
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$7.23M
2
DM
Deerfield Management
New York
-$3.23M
3
UBS Group
UBS Group
Switzerland
-$3.04M
4
AVM
Arch Venture Management
Illinois
-$2.46M
5
QM
QVIDTVM Management
Texas
-$1.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tang Capital Management
California
– -$7.23M -372,000 Closed
DM
2
Deerfield Management
New York
– -$3.23M -166,162 Closed
UBS Group
3
UBS Group
Switzerland
– -$3.04M -156,254 Closed
AVM
4
Arch Venture Management
Illinois
– -$2.46M -126,630 Closed
QM
5
QVIDTVM Management
Texas
– -$1.63M -83,671 Closed
Fidelity Investments
6
Fidelity Investments
Massachusetts
– -$1.37M -70,653 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$1.21M -62,418 Closed
Geode Capital Management
8
Geode Capital Management
Massachusetts
– -$350K -17,990 Closed
HighTower Advisors
9
HighTower Advisors
Illinois
– -$342K -17,607 Closed
BlackRock
10
BlackRock
New York
– -$295K -15,165 Closed
TM
11
Tikvah Management
North Carolina
– -$205K -10,561 Closed
PCM
12
PenderFund Capital Management
British Columbia, Canada
– -$59.3K -2,105 Closed
JP Morgan Chase
13
JP Morgan Chase
New York
– -$38.1K -1,944 Closed
Morgan Stanley
14
Morgan Stanley
New York
– -$36.8K -1,896 Closed
TRCT
15
Tower Research Capital (TRC)
New York
– -$23.1K -1,189 Closed
Barclays
16
Barclays
United Kingdom
– -$7.95K -409 Closed
Bank of America
17
Bank of America
North Carolina
– -$7.17K -369 Closed
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– -$1K -67 Closed
BNP Paribas Financial Markets
19
BNP Paribas Financial Markets
France
– -$661 -34 Closed
HI
20
Harbour Investments
Wisconsin
– -$97 -5 Closed

OMIC Hedge Fund Activity: Q1 2025 in Review

0 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q1 2025, worth a combined $0 — down 100% from $21.5M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of OMIC and 0 opened new positions — a net loss of 20 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Tang Capital Management, exiting entirely with an estimated $7.23M sold.

  • 0 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q1 2025, down from 20 in Q4 2024.
  • Funds reported $0 of Singular Genomics Systems, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q1 2025 and 20 closed out, a net change of -20 holders.
  • The largest Singular Genomics Systems, Inc. Common Stock seller in Q1 2025 was Tang Capital Management, an estimated $7.23M sold.

Based on aggregated 13F filings for Q1 2025.